1. Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancer
   Satoru Nihei et al, 2023, Cancer Chemotherapy and Pharmacology CrossRef
2. Onconephrology and Thrombotic Microangiopathy: Looking Beyond the Horizon
   Prakash Gudsoorkar et al, 2022, Seminars in Nephrology CrossRef
3. Ocular and systemic vascular endothelial growth factor ligand inhibitor use and nephrotoxicity: an update
   Dharshan Rangaswamy et al, 2024, International Urology and Nephrology CrossRef
4. Cardiac and Nephrological Complications Related to the Use of Antiangiogenic and Anti-Programmed Cell Death Protein 1 Receptor/Programmed Cell Death Protein 1 Ligand Therapy
   Paulina Stachyra-Strawa et al, 2024, Genes CrossRef
5. Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives
   Rajesh N. Gacche, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef